6 versus 12 months of adjuvant trastuzumab for HER2-positive early

6 versus 12 months of adjuvant trastuzumab for HER2-positive early trastuzumab 1 ยาพุ่งเป้า HER2 ที่ตัวรับ HER2 ที่ผิวเซลล์มะเร็ง แบ่งเป็น 2 ชนิด · Monoclonal antibody ออกฤทธิ์นอกเซลล์ ได้แก่ pertuzumab, trastuzumab ( trastuzumab Possible Side Effects of Trastuzumab · Heart Problems · Infusion-Related Side Effects · Lung Problems · Low White Blood Cell Count (Leukopenia

trastuzumab Trastuzumab prolongs survival in metastatic breast cancer patients whose tumors over express HER2 It is effective when given as a single agent or in

trastuzumab trastuzumab beyond progression Trastuzumab is generally well tolerated and does not cause many of the toxicities or side effects seen with conventional Cardiotoxicity Trastuzumab is a monoclonal antibody tyrosine kinase inhibitor that targets the HER2 receptor often over overexpressed or overactive in breast